Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder

Mary Peeler, Kevin Fiscella, Mishka Terplan, Carolyn Sufrin

Research output: Contribution to journalArticle

Abstract

Pregnant women represent a unique population for correctional facilities to care for. The incarcerated pregnant population is at an increased risk of concurrent opioid use disorder (OUD) that requires specialized care. The evidence-based best practice and standard of care for pregnant women with OUD is medication-assisted treatment (MAT) with methadone or buprenorphine pharmacotherapy. Correctional facilities that house women must be prepared to provide this care in a timely manner upon intake in order to address the serious medical needs of the pregnant woman and her fetus. Providing MAT in the incarceration setting has distinctive logistics that must be considered. This article recommends strategies to optimize the care of pregnant incarcerated women with OUD, emphasizing the importance of appropriate counseling and treatment with opioid agonist pharmacotherapy.

Original languageEnglish (US)
JournalJournal of Correctional Health Care
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Practice Guidelines
Opioid Analgesics
Pregnant Women
Drug Therapy
Buprenorphine
Evidence-Based Practice
Methadone
Standard of Care
Population
Counseling
Fetus
Therapeutics

Keywords

  • correctional health care
  • incarcerated women
  • medication-assisted treatment
  • opioid use disorder
  • pregnancy

ASJC Scopus subject areas

  • Community and Home Care
  • Public Health, Environmental and Occupational Health

Cite this

Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder. / Peeler, Mary; Fiscella, Kevin; Terplan, Mishka; Sufrin, Carolyn.

In: Journal of Correctional Health Care, 01.01.2019.

Research output: Contribution to journalArticle

@article{3f093ae024c1487ca8e43590f6a2d737,
title = "Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder",
abstract = "Pregnant women represent a unique population for correctional facilities to care for. The incarcerated pregnant population is at an increased risk of concurrent opioid use disorder (OUD) that requires specialized care. The evidence-based best practice and standard of care for pregnant women with OUD is medication-assisted treatment (MAT) with methadone or buprenorphine pharmacotherapy. Correctional facilities that house women must be prepared to provide this care in a timely manner upon intake in order to address the serious medical needs of the pregnant woman and her fetus. Providing MAT in the incarceration setting has distinctive logistics that must be considered. This article recommends strategies to optimize the care of pregnant incarcerated women with OUD, emphasizing the importance of appropriate counseling and treatment with opioid agonist pharmacotherapy.",
keywords = "correctional health care, incarcerated women, medication-assisted treatment, opioid use disorder, pregnancy",
author = "Mary Peeler and Kevin Fiscella and Mishka Terplan and Carolyn Sufrin",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/1078345818819855",
language = "English (US)",
journal = "Journal of Correctional Health Care",
issn = "1078-3458",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder

AU - Peeler, Mary

AU - Fiscella, Kevin

AU - Terplan, Mishka

AU - Sufrin, Carolyn

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Pregnant women represent a unique population for correctional facilities to care for. The incarcerated pregnant population is at an increased risk of concurrent opioid use disorder (OUD) that requires specialized care. The evidence-based best practice and standard of care for pregnant women with OUD is medication-assisted treatment (MAT) with methadone or buprenorphine pharmacotherapy. Correctional facilities that house women must be prepared to provide this care in a timely manner upon intake in order to address the serious medical needs of the pregnant woman and her fetus. Providing MAT in the incarceration setting has distinctive logistics that must be considered. This article recommends strategies to optimize the care of pregnant incarcerated women with OUD, emphasizing the importance of appropriate counseling and treatment with opioid agonist pharmacotherapy.

AB - Pregnant women represent a unique population for correctional facilities to care for. The incarcerated pregnant population is at an increased risk of concurrent opioid use disorder (OUD) that requires specialized care. The evidence-based best practice and standard of care for pregnant women with OUD is medication-assisted treatment (MAT) with methadone or buprenorphine pharmacotherapy. Correctional facilities that house women must be prepared to provide this care in a timely manner upon intake in order to address the serious medical needs of the pregnant woman and her fetus. Providing MAT in the incarceration setting has distinctive logistics that must be considered. This article recommends strategies to optimize the care of pregnant incarcerated women with OUD, emphasizing the importance of appropriate counseling and treatment with opioid agonist pharmacotherapy.

KW - correctional health care

KW - incarcerated women

KW - medication-assisted treatment

KW - opioid use disorder

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85059898278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059898278&partnerID=8YFLogxK

U2 - 10.1177/1078345818819855

DO - 10.1177/1078345818819855

M3 - Article

C2 - 30616487

AN - SCOPUS:85059898278

JO - Journal of Correctional Health Care

JF - Journal of Correctional Health Care

SN - 1078-3458

ER -